We enter partnerships that make good scientific sense and have strong business value, regardless of modality or technology.

Our Business Development professionals in North America (New Jersey), Europe (Ireland) and China (Nanjing) are dedicated to creating collaborations that are mutually beneficial and have the potential to positively impact the lives of patients.

Our areas of focus for business development are:

Innovations in cell therapy
Oncology
Immune cell biology and engineering

As a partner, we provide end-to-end capabilities for cell therapies from discovery to commercialization.

Comprehensive R&D capabilities

High-throughput antibody screening and engineering
Proprietary methodologies to optimize CAR-T constructs
Pre-clinical validation

Rapidly advancing clinical assets

Relationships with leading clinicians to rapidly advance our pipeline and platforms
Maintaining focus on quality and compliance throughout clinical development

A global manufacturing network

Three manufacturing facilities capable of producing clinical and commercial CAR-T supplies
Industry-leading technologies and service providers to innovate the CAR-T manufacturing process, optimize the end-to-end supply chain, and streamline the product delivery model

A best-in-class global commercialization

Deep experience in cell therapy commercial strategy and execution
End-to-end commercial CAR-T operational excellence
Highly specialized commercial sales and educational teams

We’re ready to speak with you.

Please know there is no guarantee that the agents discussed will receive health authority approval or become commercially available in any country for the uses being investigated .

Collaborations

We enter partnerships that make good scientific sense and have strong business value, regardless of modality or technology.

Comprehensive R&D capabilities

Rapidly advancing clinical assets

A global manufacturing network

A best-in-class global commercialization

You are about to leave LegendBiotech.com

Collaborations

We enter partnerships that make good scientific sense and have strong business value, regardless of modality or technology.

Comprehensive R&D capabilities

Rapidly advancing clinical assets

A global manufacturing network

A best-in-class global commercialization

Related